Given that both β-catenin and RAS are stabilized in CRC patient tissues mostly having APC mutations and that EGFR is a transcriptional target of the Wnt/β-catenin pathway, we tested whether expression levels of β-catenin, RAS, and EGFR are correlated in CRC patient tissues. The gene discussed is EGFR; the disease is colorectal carcinoma.